|
⚲
|
| Keyboard |
| Lars Ekman | |
|---|---|
| Firm | |
| Address | 2930 Domingo Ave, Suite 145 Berkeley, CA 94705 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Aeovian Pharmaceuticals Inc | 021-567748 | Director | 55.0 M of 55.0 M |
||
| Sophiris Bio Inc | 021-348192 | Director | 5.1 M of 5.1 M |
||
| Poseida Therapeutics Inc | 021-292050 | Director | 11.2 M of 15.0 M |
||
| Poseida Therapeutics Inc | 021-253835 | Director | 23.0 M of 36.0 M |
||
| Ocera Therapeutics Inc | 021-206724 | Director | 28.0 M of 28.0 M |
||
| Ocera Therapeutics Inc | 021-200184 | Director | |||
| Ocera Therapeutics Inc | 021-199732 | Director | |||
| Ocera Therapeutics Inc | 021-199755 | Director | 20.0 M | ||
| Cebix Inc | 021-184060 | Director | 33.2 M of 34.9 M |
||
| ARYX Therapeutics Inc | 021-147064 | Director | 2.0 M of 5.0 M |
||
| ARYX Therapeutics Inc | 021-124990 | Director | 0.4 M of 35.4 M |
||
| Amarin Corp PLC UK | 021-135720 | Director | 70.0 M of 70.0 M |
||
| Cebix Inc | 021-121648 | Executive Officer | 8.8 M of 9.0 M |
||